| PDF (285kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-158727
- DOI to cite this document:
- 10.5283/epub.15872
Abstract
Anthralin [1,8-dihydroxy-9(10H)-anthracenone] is among the most widely used drugs in the topical treatment of psoriasis1). However, not much is known concerning its mode of action at the molecular level, although a variety of cellular targets have been implicated both in the main and side effects of anthralin2 ). In particular, the interaction of anthralin with proteins has long been ...

Owner only: item control page